EMEA-000126-PIP01-07
Key facts
Invented name |
Alimta
|
Active substance |
pemetrexed disodium
|
Therapeutic area |
Oncology
|
Decision number |
P/34/2009
|
PIP number |
EMEA-000126-PIP01-07
|
Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Eli Lilly and Company Limited (US)
Tel.: +1 31 75448941 |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|